This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Should Invesco Dividend Achievers ETF (PFM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for PFM
The Zacks Analyst Blog Highlights Becton Dickinson, Phibro Animal Health, McKesson, and UnitedHealth Group
by Zacks Equity Research
Becton Dickinson, Phibro Animal Health, McKesson, and UnitedHealth Group are part of top Analyst Blog.
UnitedHealth (UNH) to Post Q1 Earnings: What to Expect
by Zacks Equity Research
UnitedHealth Group's (UNH) first-quarter results are likely to reflect the benefits of improving premiums and products.
Bet on These 4 Low-Beta, High-Dividend MedTech Stocks for 2022
by Riya Anand
Stocks like Becton, Dickinson and Company (BDX), Phibro Animal Health (PAHC), McKesson Corporation (MCK) and UnitedHealth Group Inc (UNH) are right picks with strong fundamentals.
The Joint (JYNT) Buys Northern California Regional Developer Zone
by Zacks Equity Research
The Joint (JYNT) expects the Northern California region to hold 75 clinics, including its right to oversee 56 franchisee clinics.
Select Medical (SEM) to Open 31-Bed Hospital in Northern Ohio
by Zacks Equity Research
The new facility is likely to be a satellite unit of Select Medical Holdings' (SEM) Regency Hospital Toledou, located in Sylvania, OH.
Company News for Apr 6, 2022
by Zacks Equity Research
Companies In The News Are: ZBH, CCL, UNH, CHNG, BA.
UnitedHealth Group (UNH) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $512.59, marking a +0.51% move from the previous day.
The Zacks Analyst Blog Highlights UnitedHealth Group, Johnson & Johnson, Alibaba Group Holding, Oracle and Nike
by Zacks Equity Research
UnitedHealth Group, Johnson & Johnson, Alibaba Group Holding, Oracle and Nike have been included in this Analyst Blog.
Top Research Reports for UnitedHealth, Johnson & Johnson, & Alibaba
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Johnson & Johnson (JNJ), and Alibaba Group Holding Limited (BABA).
UnitedHealth (UNH) to Spend $5.4B on Home-Health Profile Boost
by Zacks Equity Research
UnitedHealth (UNH) intends to combine its Optum business with LHC Group to expand its reach in the healthcare-at-home market.
LHC Group's (LHCG) Deal With Optum to Boost Value-Based Care
by Zacks Equity Research
LHC Group's (LHCG) deal with Optum is likely to enhance and extend value-based care to patients' homes.
Company News for Mar 30, 2022
by Zacks Equity Research
Companies In The News Are: FDX, UNH, LHCG, MRNA, ESLT.
Why You Should Retain Teladoc Health (TDOC) Stock for Now
by Zacks Equity Research
Teladoc Health (TDOC) is focused on making strategic partnerships to boost user numbers.
UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $513.03, marking a -0.08% move from the previous day.
UnitedHealth (UNH) Arm Optum Acquires Refresh Mental Health
by Zacks Equity Research
UnitedHealth (UNH) unit Optum's acquisition of Refresh Mental Health comes at a time when demand for behavioral health services is on the rise.
Teladoc Health's (TDOC) Virtual Care Model to Aid Companies
by Zacks Equity Research
Teladoc Health's (TDOC) first industry-standard model to help employers improve their package of telehealth services.
UnitedHealth Group (UNH) Gains 38% in a Year: More Room to Run?
by Zacks Equity Research
Continued revenue growth, management optimism surrounding the Medicaid business, several contract wins, and solid cash balance continue to drive UnitedHealth Group (UNH).
UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $506.12, moving -0.18% from the previous trading session.
UnitedHealth Group (UNH) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $507.02, marking a +1.76% move from the previous day.
New to Investing? This 1 Medical Stock Could Be the Perfect Starting Point
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
by Zacks Equity Research
Sector ETF report for FHLC
UnitedHealth Group (UNH) is a Top-Ranked Momentum Stock: Should You Buy?
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
UnitedHealth Group (UNH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $482.87, moving -1.74% from the previous trading session.
Anthem (ANTM) to be Renamed as Elevance Health for Rebranding
by Zacks Equity Research
Anthem (ANTM) intends to rename itself as Elevance Health to solidify its position in the market that goes beyond traditional insurance products.